<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(12)</volume><submitter>Wiegand SB</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>SNPs near the interferon lambda (IFNL) 3 gene are predictors for sustained virological response (SVR) in patients with chronic hepatitis C genotype (GT) 1. In addition, a dinucleotide frame shift in ss469415590 was described, which generates IFNL4. In this study, we compared the role of IFNL4 variants with IFNL3-(rs12979860) and IFNL3-(rs8099917) on response to pegylated (PEG)-IFN and Ribavirin (RBV) in patients with chronic hepatitis C GT2/3.&lt;h4>Methods&lt;/h4>We recruited 1006 patients with chronic hepatitis C and GT2/3 in a large German registry. A treatment with PEG-IFN and Ribavirin was started by 959 patients. We performed genotyping of IFNL3 (rs12979860, n = 726; rs8099917, n = 687) and of IFNL4 (ss469415590; n = 631).&lt;h4>Results&lt;/h4>Both preferable IFNL3 genotypes w</pubmed_abstract><journal>PloS one</journal><pagination>e0145622</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4689517</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.</pubmed_title><pmcid>PMC4689517</pmcid><pubmed_authors>Naumann U</pubmed_authors><pubmed_authors>Lueth S</pubmed_authors><pubmed_authors>Heidrich B</pubmed_authors><pubmed_authors>Grigorian N</pubmed_authors><pubmed_authors>Petersen J</pubmed_authors><pubmed_authors>Link R</pubmed_authors><pubmed_authors>Boker KH</pubmed_authors><pubmed_authors>Manns MP</pubmed_authors><pubmed_authors>Wiegand SB</pubmed_authors><pubmed_authors>Sarrazin C</pubmed_authors><pubmed_authors>Rogalska-Taranta M</pubmed_authors><pubmed_authors>Malfertheiner P</pubmed_authors><pubmed_authors>Wedemeyer H</pubmed_authors><pubmed_authors>Cornberg M</pubmed_authors><pubmed_authors>John C</pubmed_authors><pubmed_authors>Susser S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.</name><description>&lt;h4>Background&lt;/h4>SNPs near the interferon lambda (IFNL) 3 gene are predictors for sustained virological response (SVR) in patients with chronic hepatitis C genotype (GT) 1. In addition, a dinucleotide frame shift in ss469415590 was described, which generates IFNL4. In this study, we compared the role of IFNL4 variants with IFNL3-(rs12979860) and IFNL3-(rs8099917) on response to pegylated (PEG)-IFN and Ribavirin (RBV) in patients with chronic hepatitis C GT2/3.&lt;h4>Methods&lt;/h4>We recruited 1006 patients with chronic hepatitis C and GT2/3 in a large German registry. A treatment with PEG-IFN and Ribavirin was started by 959 patients. We performed genotyping of IFNL3 (rs12979860, n = 726; rs8099917, n = 687) and of IFNL4 (ss469415590; n = 631).&lt;h4>Results&lt;/h4>Both preferable IFNL3 genotypes w</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-05-05T19:58:56.221Z</modification><creation>2019-03-26T22:56:42Z</creation></dates><accession>S-EPMC4689517</accession><cross_references><pubmed>26699619</pubmed><doi>10.1371/journal.pone.0145622</doi></cross_references></HashMap>